🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I study to investigate the safety and tolerability of AZD48...
Status
Completed
Location
Research Site
Start Date
2017-05-15
Trial ID
NCT03136991
The purpose of this study was to determine the appropriate dosing regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-13
Trial ID
NCT01697579
Treatments Being Tested
Plaque psoriasis vulgaris is a chronic inflammatory skin disorder, affectin...
Status
Completed
Location
Research Site
Start Date
2016-12-09
Trial ID
NCT02976831
The current study is designed to assess the safety, tolerability, pharmacok...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06
Trial ID
NCT02798991
Treatments Being Tested
To assess the safety, tolerability, biomarker, cognitive, and clinical effi...
Status
Active Not Recruiting
Location
University of Alabama in Birmingham
Start Date
2021-12-22
Trial ID
NCT05269394
Treatments Being Tested
This study is a single-center, double-blind, randomized, placebo-controlled...
Status
Terminated
Location
Centre For Human Drug Research; Research
Start Date
2014-12-15
Trial ID
NCT02321384
Debio 1450-103 is a trial to study the pharmacokinetics (PK) of an experime...
Status
Completed
Location
Early Phase Clinical Unit
Start Date
2014-08
Trial ID
NCT02214433
The purpose of this study is to evaluate the safety and tolerability of mul...
Status
Active Not Recruiting
Location
Site DE49001
Start Date
2020-09-09
Trial ID
NCT04184895
This study is designed to assess tolerability of the weight-adjusted dose o...
Status
Completed
Location
The Lindner Research Center
Start Date
2019-02-18
Trial ID
NCT03844191
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of tenofovi...
Status
Completed
Location
Midway Immunology and Research center
Start Date
2013-10-25
Trial ID
NCT01967940
Treatments Being Tested